Bristol's cancer treatment meets main goal in late-stage trial
March 9 (Reuters) - Bristol Myers Squibb BMY.N on Monday said its experimental cancer treatment met the main goal of a late-stage study. (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb Co
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: Bristol Myers Squibb Announces Dividend
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Izalontamab Brengitecan Shows Significant OS And PFS Improvements In TNBC And ESCC